跳至主要内容
临床试验/NCT05637229
NCT05637229已完成不适用

A Serosurvey Study of Hand, Foot, and Mouth Disease in Healthy Children Aged 6 to 71 Months Old in Bandung and West Bandung District, Indonesia

Sinovac Biotech Co., Ltd2 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年11月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
600
试验地点
2
主要终点
Seroprevalence of EV71 antibodies

研究概览

简要总结

This study is a sero-survey study of infants aged 6 months to 71 months in Bandung City and West Bandung District. As initial data to find out how many children have been exposed to human enterovirus type 71 (HEV-71) which causes Hand, foot, and mouth disease (HFMD).

详细描述

This study is a cross-sectional seroprevalence survey of EV-71, associated with HFMD, among children aged between 6 to 71 months in Bandung, sampled from urban and rural Primary Health Center in Bandung, Indonesia. This study was implemented by Department of Child Health Hasan Sadikin General Hospital/Medical Faculty Universitas Padjadjaran Bandung, West Java. Age-stratified sample of 600 children aged 6-71 months will be conducted from these sites. Samples testing includes routine blood counts, enzyme-linked immunosorbent assays (ELISAs) for enterovirus type 71 (EV71) IgG and ELISAs for other HFMD-associated enteroviruses.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
6 Months 至 71 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Children aged 6 months to 71 months.
  • The participant's parent/guardian receives an explanation and receives a Letter of Consent after the explanation (informed consent) and provided a documented informed consent by parents/legally accepted representative (LAR) participants prior to the study procedures.
  • Domicile in Bandung and West Bandung District for at least 6 months.

排除标准

  • Children with difficulty to withdraw the blood during blood collection
  • Children with severe illness who require further treatment

结局指标

主要结局

Seroprevalence of EV71 antibodies

时间窗: Immediately after sampling

Proportion of participants who are seropositive (IgG) for EV-71 and proportion of participants who are seropositive for EV-71 per predefined age-groups (6 - 35 months and 36 - 71 months)

次要结局

  • Proportion of abnormality result for Routine blood tests(Immediately after sampling)
  • seroprevalence of other HFMD-associated enteroviruses antibodies(Immediately after sampling)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验